Animal studies have been carried out and additional studies on human cadavers have been completed. The next step is approval from the FDA, which may be received by the end of this year. These injectable chemicals will impact people throughout the world.
A trauma surgeon and veteran of the Iraq and Afghanistan wars, David King, has been working with Arsenal Medical and researchers from two U.S. universities to develop liquid polymers that can be injected into the abdomens of humans. The resulting chemical reaction creates an expanding foam that can slow internal bleeding, giving trauma victims additional time to receive life-saving medical care.
It’s great to see a veteran leading in the development of a life-saving medical treatment!